How a respectable chiral separation scientist got sucked into the weird, wonderful, and unpredictable field of novel psychoactive substances.

We ask Peter Harrington whether artificial intelligence can help solve the field’s big data challenges.

Rigorous analysis is vital to keep cannabis consumers safe – and help drive forward medical advances.

The potential market for complex generics is substantial, but navigating the FDA’s guidance for proving “sameness” is a real minefield...

A new polarization transfer technique promises improved sensitivity and rapid analysis times.

Measuring gaseous biomarkers to help diagnose and monitor gut disorders.

Which insecticide-infused mosquito nets are still effective? Mass spec has the answer.

Different glycosylation patterns in patients with idiopathic REM sleep behavior disorder could predict the future onset of neurodegenerative disease.

Three connoisseurs of CE discuss the hot topics in the field.

The cannabis industry is moving into the mainstream – and the big analytical players are on board.